Tag: FDA
Future Role of Authorized Generics: Market Outlook
Authorized generics let brand drugmakers sell their own drugs under generic labels after patent expiry. With new FDA rules and rising biosimilar competition, their role is shifting from market control to managed transition-impacting prices, access, and competition.
Clinical Trial Data vs Real-World Outcomes: Key Differences Explained
Explore the key differences between clinical trial data and real-world evidence, their methodological gaps, regulatory roles, and how hybrid designs are shaping modern healthcare.
Popular Posts
